GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, is proud to announce that its PERLE™ breast implant is featured in a recent independent peer-reviewed article in the Aesthetic Surgery Journal…
Medical device and technology company Lazurite® announced that a new article just published in the Journal of Orthopaedic Experience & Innovation provides key support for the usability of the company’s ArthroFree® wireless surgical camera. In a human factors usability analysis of the…
Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to acquire…
Field trial results confirm nitrogen-fixing microbial seed treatment products increased yields and reduced fertilizer use in vegetable crops like potatoes -BioConsortia, Inc., a leading agricultural technology company that designs and licenses advanced microbial products to reduce the ecological impacts of…
Navidea Biopharmaceuticals, Inc. announced today the filing of Form 15 to voluntarily deregister and suspend SEC reporting obligations. The company maintains strategic focus on its Fix, Fund, Propel approach. Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the “Company”), a company…
-London North West University Healthcare NHS Trust (LNWH) unites multiple geographically distinct hospitals with PhenoTips’ cloud-hosted Genomic Health Record (GHR) to digitize genomics and deliver on “Our Way Forward” 5-year plan. LNWH’s ambitious 5-year strategy, “Our Way Forward”, will see…
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time…
–Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, announced today the appointment of Dr. Nicola Groth, MD, PhD to its executive committee as Chief Medical Officer. She brings over 25 years…
Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale -Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene…
, Peach State Health Plan, a care management organization that serves the needs of Georgians through a range of health insurance solutions and a wholly owned subsidiary of Centene Corporation (NYSE: CNC), and the Centene Foundation, the philanthropic arm of Centene Corporation, announced a $2.2 million funding…
Centene Corporation (NYSE: CNC) issued a reminder today that it will release its 2023 fourth quarter and full year financial results at approximately 6 a.m. ET on Tuesday, February 6, 2024, and host a conference call at 8:30 a.m. ET to review the results.…
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene’s core services operations Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier…